Home Therapy in Georgia

Haselmeier GmbH, the drug delivery device business of medmix, is a global manufacturer of subcutaneous self-injection devices. The company specializes in pre-filled syringe (PFS)-based autoinjectors and cartridge-based injection pens (disposable and reusable). Product platforms include PiccoJect™, a compact 2-step autoinjector; D-Flex™, a fixed-dose injection pen; Re-Vario™, a reusable variable-dose pen; and in-pen reconstitution systems for freeze-dried biologics. Haselmeier operates manufacturing facilities in the EU (Germany, Czech Republic), USA (Georgia), and India, serving pharmaceutical and biopharmaceutical companies developing injectable therapies. The company offers comprehensive services spanning device consulting, industrialization, manufacturing, project management, life cycle management, and quality assurance. Quality management systems meet international standards. Haselmeier emphasizes patient-focused design (hidden needle technology, ease of use) and sustainability through ESG-integrated business goals. The organization brings over a century of combined experience in drug delivery and serves clients globally across EMEA, North America, and Asia-Pacific regions.

GBUK Group Limited is a UK-based medical device developer and distributor serving the NHS and global healthcare markets for over 16 years. The company designs, manufactures, and distributes a comprehensive portfolio of consumable and specialty medical devices across six core therapy areas: continence care, enteral feeding devices, patient handling, surgical & critical care, vascular access solutions, and wound management. Product offerings include IV cannulas, syringes, needle-free vascular solutions, enteral feeding bottles and adaptors, wound dressings and management supplies, patient handling equipment, and surgical consumables used in operating theatres and high-dependency units. GBUK reports 700,000 products used daily across healthcare settings. The company emphasizes technical excellence, innovation, and sustainability, with a commitment to low-carbon product delivery supporting net-zero healthcare initiatives. Manufacturing and distribution capabilities serve hospital systems, emergency departments, and home healthcare providers. All products are designed with clinical efficiency and patient comfort in mind. The company maintains an active presence at major UK and US healthcare conferences and events.

Motus Nova designs and manufactures FDA Class I cleared robotic exoskeletons for at-home neurological rehabilitation, specializing in stroke recovery and brain injury recovery. The company's flagship products—Motus Hand and Motus Foot—are active-assist robotic devices that deliver clinic-quality therapy in patient homes. These pneumatic-driven systems provide high-dose, gamified rehabilitation using constraint-induced movement therapy and interactive games to enhance motor function, strength, and fine motor control. Available via subscription model (typically $10/hour of use), the devices are covered by most major insurances including Medicare. Motus systems include integrated touchscreen monitoring, real-time progress tracking, clinical support, and personalized therapy protocols. Since 2020, over 3,000 home units have been deployed across all 50 states, with approximately 200 additional devices in clinical settings. Clinical trials at Emory and VA hospitals demonstrated equivalent outcomes between robotic and therapist-delivered therapy, with 82% of users reporting functional improvements within months.

RehabMart is a B2B/B2C e-commerce platform specializing in adaptive equipment, assistive devices, and rehabilitation products for individuals with disabilities, special needs, and medical conditions. Founded nearly 20 years ago by a Pediatric Occupational Therapist and operated by occupational and physical therapy professionals, the company supplies healthcare facilities, rehabilitation clinics, schools, home health organizations, VA, and individual caregivers. Product portfolio includes patient lifts (standing, Hoyer, specialty), mobility aids (wheelchairs, walkers, rollators), hospital beds, wheelchair cushions and ramps, bathroom safety equipment (bath lifts, shower chairs), physical therapy devices (parallel bars, mat tables, continuous passive motion machines), oxygen delivery systems (concentrators, CPAP), gait trainers, therapeutic ultrasound, cryotherapy, lymphedema pumps, special needs protective helmets, seating systems, and daily living aids. Offers installation, service, and repair support; financing options; and curated product collections for veterans, schools, and builders.

Avanos Medical, Inc. is a specialized medical device manufacturer focused on two core therapeutic areas: enteral feeding solutions and pain management & recovery. The company develops and markets a comprehensive portfolio of specialty nutrition delivery systems for neonates, pediatric, adult, and geriatric patients, along with non-opioid pain management and post-operative recovery solutions. Key product lines include MIC-KEY® low-profile feeding tubes, CORTRAK® NG tube guidance systems, NEOMED® neonatal solutions, GAME READY® cryo-compression therapy, COOLIEF® cooled radiofrequency systems, and ON-Q® elastomeric infusion pumps. The ON-Q® and ambIT® infusion pumps are recognized under the CMS NOPAIN Act (effective January 1, 2025) as qualifying non-opioid pain management solutions eligible for separate reimbursement. Avanos serves critical care physicians, anesthesiologists, interventional pain specialists, orthopedic surgeons, sports medicine practitioners, neonatologists, and NICU professionals. The company operates a direct customer portal for online ordering, maintains a 24/7 nurse hotline for surgical pain product support, and provides sales representation across North America. Avanos markets solutions emphasizing improved patient outcomes, reduced opioid dependency, and clinical efficacy in both acute surgical settings and chronic pain management.

Pain Care Labs (dba MMJ Labs) is a leader in noninvasive, drug-free pain relief devices founded in 2006 by Dr. Amy Baxter, a pediatric emergency physician and pain researcher. Headquartered in Atlanta, GA, the company manufactures FDA 510(k)-cleared wearable medical devices utilizing patented mechanical stimulation (M-Stim™) technology, vibration frequencies, and thermal therapies to activate the body's natural pain response system. The company's product portfolio includes Buzzy® (needle pain and fear management for vaccinations, phlebotomy, IV access, and injections, with over 37 million documented procedures); VibraCool® (focal muscle vibration therapy for acute and chronic musculoskeletal pain, post-surgical recovery, and injury management); Buzzy® Pro (adult-focused version for dialysis and blood draw procedures); VibraCool® Pro (intensive M-stim with modular heat and ice for clinical settings); and DuoTherm (patent-pending low back pain brace combining M-stim vibrations with thermal therapy). All devices are rechargeable, reusable, and FDA-cleared. Products are deployed in over 5,000 hospitals and clinics across 28 countries. Pain Care Labs emphasizes cost-effectiveness, clinical evidence (50+ independent studies), patient satisfaction, and opioid-reduction strategies. Distribution includes retail channels (CVS) and direct-to-consumer, healthcare professional, and pharmaceutical partnership models.

Sensica Inc. is a medical equipment manufacturer headquartered in Atlanta, Georgia, specializing in at-home aesthetic devices that deliver professional-grade treatments for anti-aging, hair removal, and body contouring. Founded in 2012, the company leverages over 20 years of aesthetic innovation expertise (including 3 patents) to translate expensive clinical-grade technologies into affordable, portable handheld systems for consumer use. Sensica's core product line includes Sensilight™ Pro (Reactive Pulsed Light IPL for permanent hair reduction), Sensilift™ (Dynamic RF™ for facial lifting and collagen stimulation), and Sensifirm™ (Lipotherm RF™ for body sculpting and cellulite reduction). All devices feature integrated thermal sensors, adaptive energy output, and skin-tone detection for safe, consistent treatment across diverse skin types (I–V). The company reports 5 million+ treatments delivered, FDA clearance, and support from 7+ peer-reviewed clinical studies. Sensica emphasizes user accessibility through 5–20 minute sessions, personalized treatment protocols, 90-day satisfaction guarantees, and direct consumer support from professional estheticians.